M&A Deal Summary |
|
---|---|
Date | 2006-03-29 |
Target | Terapia SA |
Sector | Life Science |
Buyer(s) | Ranbaxy Laboratories |
Sellers(s) | Advent International |
Deal Type | Add-on Acquisition |
Deal Value | 324M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1961 |
Sector | Life Science |
Employees | 15,300 |
Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Life Science) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Romania) | 1 of 1 |
Year (2006) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-10-03 |
Zenotech Laboratories
Hyderabad, India Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company, manufactures bio-technology products. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1984 |
PE ASSETS | 76.0B USD |
Size | Mega |
Type | Sector Agnostic |
Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 69 of 222 |
Sector (Life Science) | 8 of 12 |
Type (Add-on Acquisition) | 30 of 82 |
Country (Romania) | 3 of 7 |
Year (2006) | 4 of 15 |
Size (of disclosed) | 36 of 52 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-02-21 |
Fada Pharma SA
Munro, Argentina Fada Pharma SA is a major supplier to the nation’s leading healthcare institutions, such as Fleming, Fundacion Favaloro, Hospital Italiano, Hospital Britanico and the Ministry of Health. It also sells to nearly all major private hospitals in the Buenos Aires metropolitan area as well as to clinics and retail pharmacies across the country. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-05-01 |
CSU CardSystem SA
Barueri, Brazil Largest independent credit card administrator in Brazil. IPO on BOVESPA (CARD3). |
Sell | - |